IndraLab

Statements

5-isoquinolinesulfonic acid [4-[(2S)-2-[5-isoquinolinylsulfonyl(methyl)amino]-3-oxo-3-(4-phenyl-1-piperazinyl)propyl]phenyl] ester inhibits CASP1. 1 / 1

| 1

reach

"Although we did observe ATP release from LPS treated neutrophils (XREF_SUPPLEMENTARY), KN62 failed to block caspase-1 activation or IL-1beta production (XREF_FIG)."

22496641

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

5-isoquinolinesulfonic acid [4-[(2S)-2-[5-isoquinolinylsulfonyl(methyl)amino]-3-oxo-3-(4-phenyl-1-piperazinyl)propyl]phenyl] ester inhibits CASP1. 1 / 1

INDRA sources:

Databases

Reading